IN192381B - - Google Patents
Info
- Publication number
- IN192381B IN192381B IN1292DE2002A IN192381B IN 192381 B IN192381 B IN 192381B IN 1292DE2002 A IN1292DE2002 A IN 1292DE2002A IN 192381 B IN192381 B IN 192381B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1292DE2002 IN192381B (es) | 2002-12-20 | 2002-12-20 | |
| RU2005121999/15A RU2005121999A (ru) | 2002-12-20 | 2003-12-18 | Фармацевтические композиции тамсулозина с контролируемым высвобождением |
| JP2004561893A JP2006512358A (ja) | 2002-12-20 | 2003-12-18 | タムスロシンの放出制御薬剤組成物 |
| CNA2003801094133A CN1744889A (zh) | 2002-12-20 | 2003-12-18 | 坦洛新的控释药物组合物 |
| EP03780445A EP1596849A1 (en) | 2002-12-20 | 2003-12-18 | Controlled release pharmaceutical compositions of tamsulosin |
| PCT/IB2003/006072 WO2004056354A1 (en) | 2002-12-20 | 2003-12-18 | Controlled release pharmaceutical compositions of tamsulosin |
| CA002511208A CA2511208A1 (en) | 2002-12-20 | 2003-12-18 | Controlled release pharmaceutical compositions of tamsulosin |
| AU2003288604A AU2003288604A1 (en) | 2002-12-20 | 2003-12-18 | Controlled release pharmaceutical compositions of tamsulosin |
| BR0317567-7A BR0317567A (pt) | 2002-12-20 | 2003-12-18 | Composição farmacêutica de liberação controlada de tamsulosina e processo para sua preparação |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1292DE2002 IN192381B (es) | 2002-12-20 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN192381B true IN192381B (es) | 2004-04-10 |
Family
ID=32676755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1292DE2002 IN192381B (es) | 2002-12-20 | 2002-12-20 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1596849A1 (es) |
| JP (1) | JP2006512358A (es) |
| CN (1) | CN1744889A (es) |
| AU (1) | AU2003288604A1 (es) |
| BR (1) | BR0317567A (es) |
| CA (1) | CA2511208A1 (es) |
| IN (1) | IN192381B (es) |
| RU (1) | RU2005121999A (es) |
| WO (1) | WO2004056354A1 (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1600157A4 (en) * | 2003-01-27 | 2006-02-08 | Astellas Pharma Inc | FINE DARK ARTICLES WITH DELAYED RELEASE FOR TAMSULOSINE OR ITS SALTS AND METHOD OF PREPARATION THEREOF |
| EP2112920B1 (en) | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
| US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
| ATE363894T1 (de) * | 2004-07-14 | 2007-06-15 | Siegfried Generics Int Ag | Granulat zur kontrollierten freisetzung von tamsulosin, enthaltend alginat |
| US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
| US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
| CN101453996B (zh) * | 2006-04-03 | 2016-05-11 | 伊萨·奥迪迪 | 药物递送组合物 |
| CA2648280C (en) | 2006-04-03 | 2014-03-11 | Isa Odidi | Controlled release delivery device comprising an organosol coat |
| US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
| WO2008089593A1 (fr) * | 2007-01-18 | 2008-07-31 | Standard Chem. & Pharm. Co., Ltd. | Preparation de tamsulosine a liberation prolongee et procede de production associe |
| JP5511663B2 (ja) * | 2008-07-01 | 2014-06-04 | 沢井製薬株式会社 | タムスロシン塩酸塩を含有する球形微粒子の製造方法 |
| CN101695478B (zh) * | 2009-10-23 | 2012-01-18 | 江苏大学 | 盐酸坦索罗辛缓释微丸制剂及其制备方法 |
| KR101423237B1 (ko) | 2010-05-04 | 2014-07-30 | 주식회사 삼양바이오팜 | 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 |
| CN103142492A (zh) * | 2013-02-01 | 2013-06-12 | 北京科信必成医药科技发展有限公司 | 一种缓释微丸制剂及其制备方法 |
| CN103315962A (zh) * | 2013-02-01 | 2013-09-25 | 北京科信必成医药科技发展有限公司 | 一种坦索罗辛缓释微丸制剂及其制备方法 |
| CN103919735B (zh) * | 2014-05-04 | 2018-04-17 | 翰宇药业（武汉）有限公司 | 一种盐酸坦索罗辛缓释微丸及其制备方法 |
| EP2949319A1 (en) | 2014-05-26 | 2015-12-02 | Galenicum Health S.L. | Pharmaceutical compositions comprising an active agent |
| CN109562071A (zh) * | 2016-05-04 | 2019-04-02 | 艾森潘帕克制药股份有限公司 | 延迟释放口服盐酸坦索罗辛 |
| EP3473244A1 (en) | 2017-10-20 | 2019-04-24 | Veru Inc. | Controlled release oral tamsulosin hydrochloride |
| EP3473245A1 (en) | 2017-10-20 | 2019-04-24 | Veru Inc. | Controlled release oral tamsulosin hydrochloride |
| KR20200078146A (ko) * | 2018-12-21 | 2020-07-01 | 한미약품 주식회사 | 내산성이 우수한 탐수로신 염산염 함유 제약 조성물 및 이의 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| EP1064938A1 (en) * | 1999-06-28 | 2001-01-03 | Sanofi-Synthelabo | Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| ATE321544T1 (de) * | 2001-11-07 | 2006-04-15 | Synthon Bv | Tamsulosin tabletten |
-
2002
- 2002-12-20 IN IN1292DE2002 patent/IN192381B/en unknown
-
2003
- 2003-12-18 RU RU2005121999/15A patent/RU2005121999A/ru not_active Application Discontinuation
- 2003-12-18 AU AU2003288604A patent/AU2003288604A1/en not_active Abandoned
- 2003-12-18 CA CA002511208A patent/CA2511208A1/en not_active Abandoned
- 2003-12-18 WO PCT/IB2003/006072 patent/WO2004056354A1/en not_active Application Discontinuation
- 2003-12-18 BR BR0317567-7A patent/BR0317567A/pt not_active Application Discontinuation
- 2003-12-18 EP EP03780445A patent/EP1596849A1/en not_active Withdrawn
- 2003-12-18 JP JP2004561893A patent/JP2006512358A/ja not_active Withdrawn
- 2003-12-18 CN CNA2003801094133A patent/CN1744889A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004056354A1 (en) | 2004-07-08 |
| EP1596849A1 (en) | 2005-11-23 |
| CA2511208A1 (en) | 2004-07-08 |
| RU2005121999A (ru) | 2006-01-20 |
| CN1744889A (zh) | 2006-03-08 |
| JP2006512358A (ja) | 2006-04-13 |
| AU2003288604A1 (en) | 2004-07-14 |
| BR0317567A (pt) | 2005-11-22 |